Bicarbonate

Bicarbonate

SCHEMBL614488

O=C([O-])[O-].O=C([O-])[O-].O=C([O-])[O-].O=C([O-])[O-].[Cu+2].[Cu+2].[Cu+2].[OH-].[OH-].[OH-].[OH-].[Zn+2].[Zn+2].[Zn+2]

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
CA4 P22748 5/20 0.42
CA1 P00915 2/20 0.42
FAHD1 Q6P587 1/20 0.42
LMNA P02545 2/20 0.33
MEN1 O00255 1/20 0.33
LDHA P00338 1/20 0.33
BLM P54132 1/20 0.33
KMT2A Q03164 1/20 0.33
CASP1 P29466 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL8054441 0.95 CA4 (0.39) CA4CA1FAHD1LMNAMEN1
Bicarbonate SCHEMBL119019 0.94
Bicarbonate SCHEMBL437197 0.94 CA4 (0.46) CA4CA1FAHD1LMNAMEN1
Bicarbonate SCHEMBL293138 0.94 CA4 (0.46) CA4CA1FAHD1LMNAMEN1
Bicarbonate SCHEMBL9576852 0.94 CA4 (0.46) CA4CA1FAHD1LMNAMEN1
Bicarbonate SCHEMBL28207811 0.94 CA4 (0.46) CA4CA1FAHD1LMNAMEN1
Bicarbonate SCHEMBL26654550 0.94 CA4 (0.46) CA4CA1FAHD1LMNAMEN1
Bicarbonate SCHEMBL4949748 0.94 CA4 (0.46) CA4CA1FAHD1LMNAMEN1
Bicarbonate SCHEMBL15189590 0.91 CA4 (0.36) CA4CA1FAHD1
Bicarbonate SCHEMBL1679609 0.89 CA4 (0.42) CA4CA1FAHD1LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 822 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1496899-B1 USE OF MATERIALS HAVING ZINC IONOPHORIC BEHAVIOR PROCTER & GAMBLE (US) 2021-06-23 EP claimed
EP-1603521-B1 AUGMENTATION OF PYRITHIONE ACTIVITY OR A POLYVALENT METAL SALT OF PYRITHIONE ACTIVITY BY ZINC-CONTAINING LAYERED MATERIAL PROCTER & GAMBLE (US) 2020-06-17 EP claimed
EP-2763653-B1 PERSONAL CARE COMPOSITIONS AND METHODS OF MAKING SAME PROCTER & GAMBLE (US) 2019-07-17 EP claimed
EP-2999455-B1 METHOD OF ACHIEVING IMPROVED PRODUCT RHEOLOGY, COSMETIC CONSUMER ACCEPTANCE AND DEPOSITION PROCTER & GAMBLE (US) 2019-05-15 EP claimed
EP-2953686-B1 HAIR CARE COMPOSITION COMPRISING CATIONIC POLYMERS AND ANIONIC PARTICULATES PROCTER & GAMBLE (US) 2019-03-27 EP claimed
CN-105338953-B Method for achieving improved product rheology, cosmetic consumer acceptance and deposition 宝洁公司 2018-09-28 CN claimed
US-9662291-B2 Method of achieving improved hair feel THE PROCTER & GAMBLE COMPANY (US) 2017-05-30 US claimed
US-9381148-B2 Composition comprising particulate zinc material with a high relative zinc lability THE PROCTER & GAMBLE COMPANY (US) 2016-07-05 US claimed
US-9381382-B2 Composition comprising a particulate zinc material, a pyrithione or a polyvalent metal salt of a pyrithione and a gel network THE PROCTER & GAMBLE COMPANY (US) 2016-07-05 US claimed
US-20160143835-A1 METHOD OF ACHIEVING IMPROVED HAIR FEEL PROCTER & GAMBLE (US) 2016-05-26 US claimed
US-20040191331-A1 Composition comprising particulate zinc materials having a defined crystallite size THE PROCTER & GAMBLE COMPANY 2004-09-30 US claimed
WO-2004082649-A1 AUGMENTATION OF PYRITHIONE ACTIVITY OR A POLYVALENT METAL SALT OF PYRITHIONE ACTIVITY BY ZINC-CONTAINING LAYERED MATERIAL THE PROCTER & GAMBLE COMPANY (US) 2004-09-30 WO claimed
WO-2004082648-A1 COMPOSITION COMPRISING PARTICULATE ZINC MATERIALS HAVING A DEFINED CRYSTALLITE SIZE THE PROCTER & GAMBLE COMPANY (US) 2004-09-30 WO claimed
EP-1412284-A2 COMPOSITION FOR TREATING CELLS AND METHODS FOR QUALITATIVELY AND QUANTITATIVELY CUSTOMIZING THE FORMULATION THEREOF FOR A HEURISTICALLY DERIVED LIVING CELL NUTRIENT-COMPOSITION-ON-DEMAND Runkis, Walter H. (US) 2004-04-28 EP claimed
US-20040058855-A1 Use of materials having zinc ionophoric behavior THE PROCTOR & GAMBLE COMPANY 2004-03-25 US claimed
US-20030215522-A1 Personal care compositions comprising a zinc containing material in an aqueous surfactant composition THE PROCTER & GAMBLE COMPANY 2003-11-20 US claimed
WO-2003088965-A1 USE OF MATERIALS HAVING ZINC IONOPHORIC BEHAVIOR THE PROCTER & GAMBLE COMPANY (US) 2003-10-30 WO claimed
WO-2003088957-A1 PERSONAL CARE COMPOSITIONS COMPRISING A ZINC CONTAINING MATERIAL IN AN AQUEOUS SURFACTANT COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 2003-10-30 WO claimed
US-20030073580-A1 Composition for treating cells and method for qualitatively and quantitatively customizing the formulation thereof RUNKIS WALTER H (US) 2003-04-17 US claimed
WO-2002100772-A2 COMPOSITION AND METHOD FOR TREATING CELLS AND PLANTS RUNKIS WALTER H (US) 2002-12-19 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040058855-A1 Use of materials having zinc ionophoric behavior SLC30A6, SLC39A7, SLC30A7 CA4 1751/4885CA1 1670/4885FAHD1 1144/4885
US-20040191331-A1 Composition comprising particulate zinc materials having a defined crystallite size PPOX, LPO, THOC2 CA4 1164/4885CA1 283/4885FAHD1 1499/4885
US-20030215522-A1 Personal care compositions comprising a zinc containing material in an aqueous surfactant composition SLC30A7, SLC39A7, SOD1 CA4 1668/4885CA1 1035/4885FAHD1 3592/4885
US-20160143835-A1 METHOD OF ACHIEVING IMPROVED HAIR FEEL POLR1C, PMP22, SUCLG1 CA4 996/4885CA1 922/4885FAHD1 1221/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.